serum-free medium aim-v , which has been approved for generating lymphokine , ( i.e. , interleukin-2 ; il-2 ) -activated killer cells ( lak ) for il-2/lak adoptive immunotherapy modalities , may also prove useful for studies defining and isolating regulatory proteins produced by activated monocytes and macrophages and for generating cytolytic macrophages for different antitumor regimens .
C0022687
lak
C0280508
il-2/lak